 |
| Research article summary (published 21 Dec 2009): |
The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp.
Full Abstract
BACKGROUND: The JAL antigen (Rh48) was discovered more than 30 years ago when it caused hemolytic disease of the fetus and newborn in an African American family. A decade later it was found to cause hemolytic disease of the fetus and newborn in a Caucasian family. The presence of the same low-prevalence antigen in two different ethnic groups is rare, but additional JAL+ in both groups was subsequently identified. This study was undertaken to investigate the RH gene(s) responsible for expression of JAL and to determine the structural relationship between JAL and other Rh antigens. STUDY DESIGN AND METHODS: Samples from 17 JAL+ people were included: 2 Caucasian, 6 African American, 7 African Brazilian, 1 Caribbean, and 1 Puerto Rican. RHCE and RHD were investigated at the genomic level, and Rh cDNAs were cloned and sequenced for some samples. RESULTS: Caucasian JAL+ probands had RHCE*Ce, while JAL+ probands with African ancestry had RHCE*ce, but all had a nucleotide 340C>T change in Exon 3 of RHCE predicted to encode Arg114Trp. The JAL-encoding RHCE*ce also had 733C>G (Leu245Val) and was linked to conventional RHD or to RHD*DAU0. CONCLUSIONS: JAL+ results from a nucleotide 340C>T (Arg114Trp) on either a Ce or ce background. Homology modeling of the JAL+ RhCE protein suggests that the Arg-->Trp change eliminates a critical loop-stabilizing H-bond between the side chain of Arg114 and the e-specific amino acid Ala226. Additionally, accommodation of the bulky tryptophan would disrupt the conformation of the extracellular loops containing C/c- and e-specific amino acids, providing a structural hypothesis for the simultaneous altered expression of C/c, e, and V/VS antigens.
Author information
Author/s: Westhoff, Connie M (CM); Vege, Sunitha (S); Wylie, Dwane (D); Nickle, Pam (P); Lomas-Francis, Christine (C); Hue-Roye, Kim (K); Reid, Marion E (ME);
Affiliation: Molecular Blood Group and Platelet Testing Laboratory, American Red Cross, Penn-Jersey Region, Philadelphia, PA 19130, USA. westhoffc(-atsign-)usa.redcross.org
Grants: R01 HL091030-02 (Agency:NHLBI NIH HHS)
Journal and publication information
Publication Type: Journal Article
Journal: Transfusion (Transfusion), published in United States. (Language: eng)
Reference: 2009-Apr; vol 49 (issue 4) : pp 725-32
Dates: Created 2009/04/01; Completed 2009/05/01; Revised 2009/10/05;
PMID: 19170983, status: MEDLINE (last retrieval date: 10/6/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.